search tools

Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

Edit Business Wire 23 Jun 2016
LONDON--(BUSINESS WIRE)--$ABBV #CLL--Technavio has announced the top ten leading vendors in their recent global chronic lymphocytic leukemia (CLL) market report from 2016-2020 ... ....

Watch These 7 Huge Put Purchases In Tuesday Trade

Edit Stockhouse 21 Jun 2016
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday's regular session. Amgen, Inc ... ABBV) Fri 6/24 61.0 Puts (Wkly) Sweep ... ....

AbbVie Declares Quarterly Dividend

Edit PR Newswire 16 Jun 2016
NORTH CHICAGO, Ill., June 16, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE. ABBV) declared a quarterly cash dividend of $0.57 per share.  The cash dividend is payable Aug. 15, 2016 to stockholders of record at the close of business on July 15, 2016 ... ....

AbbVie Declares Quarterly Dividend (AbbVie Inc)

Edit Public Technologies 16 Jun 2016
(Source. AbbVie Inc). NORTH CHICAGO, Ill., June 16, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE. ABBV) declared a quarterly cash dividend of $0.57 per share. The cash dividend is payable Aug. 15, 2016 to stockholders of record at the close of business on July 15, 2016 ... About AbbVie ... Follow@abbvieon Twitter or view careers on ourFacebook orLinkedInpage ... Media....

One Reason Why AbbVie (ABBV) Stock Closed Up Today

Edit The Street 15 Jun 2016
NEW YORK (TheStreet) -- Shares of AbbVie (ABBV) advanced by 0.83% to $60.40 in Wednesday's trading session, after UBS wrote that the company is its favorite  "low expectations, low multiple name," Barron's reports ... Clinical data flow during the next two years should drive pipeline visibility, UBS mentioned ... ABBV ... ....

Infinity Pharmaceuticals Faces Downgrades as Drug Results Disappoint

Edit The Street 15 Jun 2016
Editor's Note. This article was originally published on Real Money at 1.30 p.m. on June 15. With uncertainty surrounding a disappointing drug study and a restructuring plan that slashes jobs, analysts have also slashed their expectations for Infinity Pharmaceuticals (INFI) ... They also downgraded Infinity to hold from buy ... Furthermore, analysts at both Wells Fargo and Jefferies predict the end of Infinity's partnership with AbbVie (ABBV) ....

SunTrust Highlights Upcoming Pharma Calendar, Favorite Names

Edit Stockhouse 13 Jun 2016
As the new week starts, SunTrust gave multiple reasons why they believe the pharmaceuticals group can outperform in 2016 ... To take advantage of pricing concerns, SunTrust reviewed what may be key meetings and conferences this week in the pharmaceuticals sector ... ABBV) ... ....

Abbvie (ABBV) Stock Downgraded at BMO Capital

Edit The Street 10 Jun 2016
NEW YORK (TheStreet) -- Abbvie  (ABBV) shares are decreasing by 0.79% to $60.27 in early afternoon trading on Wednesday, as the company's stock was downgraded to "market perform" from "outperform" at BMO Capital. The firm lowered its price target for the Chicago-based pharmaceutical company to $66 from $70 ... ABBV. ....

Analysts' Actions -- AbbVie, Corning, J.M. Smucker, Mattress Firm and More

Edit The Street 10 Jun 2016
RATINGS CHANGES. AbbVie (ABBV) was downgraded to market perform from outperform at BMO Capital. $66 price target. Uncertainty is increasing around major growth drivers, BMO said. Bojangles (BOJA) was initiated with a hold rating at TheStreet Ratings ... BOJA ... NAP ... ....

Watch These 7 Huge Call Purchases In Thursday Trade

Edit Stockhouse 09 Jun 2016
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session ... ABBV) Fri 6/10 62.5 Calls (Wkly) Sweep ... ....

AbbVie (ABBV) Stock Slides on Ratings Downgrade

Edit The Street 08 Jun 2016
NEW YORK (TheStreet) -- Shares of AbbVie (ABBV) are down by 2.36% to $61.61 in mid-afternoon trading on Wednesday, following a rating downgrade to "equal weight" from "outperform" at Morgan Stanley earlier today. . The firm cut its price target to $65 from $73 on the stock ... (AbbVie is held in David Peltier's Dividend Stock Advisor portfolio ... ABBV ... ....

Wall Street set for higher open as oil rally continues

Edit Yahoo Daily News 08 Jun 2016
By Yashaswini Swamynathan. REUTERS - Wall Street was set for a slightly higher open on Wednesday, a day after the S&P; closed at a near 11-month high, as oil prices rose again and chances of an interest rate hike in the near term faded. Oil held above $50 for the second consecutive day on supply disruptions in Nigeria, a drop in U.S. crude inventories and strong demand in China. [O/R] ... AbbVie (ABBV.N) fell 1.4 percent to $62.22....

The Market In 5 Minutes: Crude Oil Hits Highest Level In Nearly A Year

Edit Stockhouse 08 Jun 2016
Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in five minutes. Apply for daily AM access by clicking here or email [email protected] Macro Focus. The price of US WTI crude oil closed Tuesday above the $50 per barrel mark for the first time since July ... UWTI) is trading higher by nearly 4 percent this morning ... BZ News Desk Focus ... Est ... $532M vs ... ABBV) to Equal-Weight....
×
×
×
×